Activity ID
14806Expires
July 18, 2026Format Type
LiveCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry disorders.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
YesNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Differentiate dopaminergic and muscarinic mechanisms of
actions of novel therapies, and explain the clinical utility to
address unmet needs of patients with schizophrenia
Evaluate emerging clinical evidence supporting novel therapies
in schizophrenia, with attention to efficacy signals, safety
considerations, and current limitations of the data
Design strategies to integrate novel therapeutic options into
treatment plans for patients with schizophrenia while counseling
them on optimal administration and side effect management
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Inpatient, Outpatient, Rural, Urban, VA/Military
